Astronics (ATRO) Lands U.S. Army Order, Is The Stock 11% Overvalued?

Astronics (ATRO) recently received a purchase order from the U.S. Army for its TS-4549/T Radio Test Sets, moving the program into full rate production with deliveries scheduled over the next 20 months.

See our latest analysis for Astronics.

The U.S. Army order lands at a time when Astronics has already caught investors’ attention, with the share price up 16.3% over the past month and 62.4% over 90 days. The 1 year total shareholder return of 202.6% and 5 year total shareholder return above 4x highlight strong longer term momentum, despite a 1 day share price decline of 3.3% to $84.32.

If this contract win has you thinking about where else defense and aerospace technology could surprise, it may be worth scanning 35 power grid technology and infrastructure stocks

With Astronics now trading above the average analyst price target and showing very strong 1 year and multi year returns, the key question is whether investors are overpaying for recent contract wins or if the market is still underestimating future growth.

Most Popular Narrative: 11% Overvalued

The most followed Astronics narrative pegs fair value at $76.15 per share, which sits below the last close of $84.32 and points to a stretched valuation.

Strategic portfolio actions, including exiting low-margin/non-core product lines, rationalizing facilities, and a sharpened focus on higher-margin aerospace segments, are simplifying the business, improving gross margins, and supporting a sustainable step-up in net margins.

Read the complete narrative.

Want to see what kind of revenue path and margin expansion needs to line up for that fair value? The narrative leans on faster earnings growth, a richer profit profile, and a lower future earnings multiple than today. The full set of assumptions is where the real story shows up.

Result: Fair Value of $76.15 (OVERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, Astronics still faces pressure from higher tariff related costs and ongoing execution risk in its Test Systems segment, which could challenge the current narrative of overvaluation.

Find out about the key risks to this Astronics narrative.

Next Steps

If this Astronics story feels finely balanced between optimism and caution, take a closer look at the numbers and underlying assumptions now, and weigh both the risks and rewards using the 2 key rewards and 2 important warning signs

Looking for more Astronics sized investment ideas?

Do not let your research stop with Astronics. Broaden your watchlist now and give yourself more options before the next round of market moving updates hits.

• Identify potential mispricings early by reviewing companies highlighted in the 44 high quality undervalued stocks.
• Strengthen your downside protection by focusing on companies featured in the 71 resilient stocks with low risk scores.
• Stay ahead of the crowd by scanning the screener containing 19 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com